DocuSign (DOCU) stock tanks despite healthy Q1 results, with billings missing guidance and lowered full-year outlook. Hold rating reaffirmed.
Latest Ratings for DOCU
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Piper Sandler | Maintains | Neutral | |
| Mar 2022 | Wolfe Research | Maintains | Peer Perform | |
| Mar 2022 | Wells Fargo | Maintains | Equal-Weight |
